Profile data is unavailable for this security.
About the company
Merus NV is the Netherlands - based biotechnology company, concentrated on developing differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Multiclonics format. Its products are designed to bind to multiple targets, and are manufactured with features for anti-cancer effects against the complex mechanisms that drive cancer. Company's products engage cancer antigens and harness the power of the immune system to kill tumor cells by utilizing technology platform. One of the drug zenocutuzumab (Zeno), a Biclonics antibody, concentrates on helping patients with lung, pancreatic and other types of solid tumors. The company operates in the Netherlands and United States.
- Revenue in USD (TTM)45.63m
- Net income in USD-63.64m
- Incorporated2003
- Employees121.00
- LocationMerus NVYalelaan 62UTRECHT 3584 CMNetherlandsNLD
- Phone+31 302538800
- Websitehttps://merus.nl/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mersana Therapeutics Inc | 11.90m | -208.27m | 675.47m | 169.00 | -- | 7.40 | -- | 56.74 | -2.43 | -2.43 | 0.1379 | 0.9153 | 0.0447 | -- | -- | 70,437.87 | -78.23 | -52.20 | -104.23 | -70.47 | -- | -- | -1,749.59 | -547.25 | -- | -89.59 | 0.216 | -- | -94.81 | -72.04 | -93.15 | -- | -9.78 | -- |
| ANI Pharmaceuticals Inc | 283.08m | -69.20m | 678.50m | 601.00 | -- | 2.18 | -- | 2.40 | -4.48 | -4.48 | 18.00 | 19.26 | 0.4681 | 1.73 | 2.29 | 471,018.30 | -11.21 | -1.35 | -13.00 | -1.64 | 51.83 | 60.08 | -23.95 | -3.09 | 2.62 | -2.16 | 0.4599 | -- | 3.67 | 10.94 | -89.79 | -- | -10.95 | -- |
| Repare Therapeutics Inc | 120.51m | -25.68m | 680.20m | 168.00 | -- | 2.22 | -- | 5.64 | -0.7351 | -0.7351 | 2.87 | 7.29 | 0.342 | -- | 1.00 | 792,822.40 | -7.29 | -- | -8.29 | -- | -- | -- | -21.31 | -- | -- | -- | 0.00 | -- | 5,529.63 | -- | -100.14 | -- | -- | -- |
| Tango Therapeutics Inc | 24.17m | -101.16m | 681.61m | 109.00 | -- | 2.49 | -- | 28.21 | -1.15 | -1.15 | 0.2749 | 3.10 | 0.0486 | -- | 4.83 | 265,549.40 | -20.35 | -- | -22.46 | -- | -- | -- | -418.63 | -- | -- | -- | 0.00 | -- | -- | -- | -47,226.29 | -- | -- | -- |
| SNDL Inc | 368.16m | -196.77m | 682.08m | 184.00 | -- | 0.6355 | -- | 1.85 | -0.8718 | -0.8718 | 1.66 | 4.53 | 0.3023 | 4.13 | 31.89 | 2,000,864.00 | -16.24 | -- | -17.29 | -- | 22.42 | -- | -53.71 | -- | 4.78 | -0.3733 | 0.1476 | -- | -7.86 | -- | -15.41 | -- | -- | -- |
| Anavex Life Sciences Corp | 0.00 | -47.98m | 691.52m | 38.00 | -- | 4.85 | -- | -- | -0.6231 | -0.6231 | 0.00 | 1.83 | 0.00 | -- | -- | 0.00 | -30.53 | -46.07 | -32.71 | -51.22 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -26.56 | -- | -- | -- |
| Editas Medicine Inc | 25.64m | -201.13m | 691.76m | 264.00 | -- | 1.67 | -- | 26.98 | -2.93 | -2.93 | 0.3741 | 6.03 | 0.0411 | -- | 138.24 | 97,136.37 | -32.23 | -28.88 | -34.83 | -32.06 | -- | -- | -784.32 | -368.55 | -- | -- | 0.00 | -- | -71.85 | 33.37 | -65.98 | -- | 17.96 | -- |
| Alector Inc | 133.17m | -133.96m | 698.00m | 269.00 | -- | 2.76 | -- | 5.24 | -1.63 | -1.66 | 1.62 | 3.06 | 0.1575 | -- | 32.98 | 640,245.20 | -15.84 | -22.06 | -19.17 | -25.83 | -- | -- | -100.59 | -148.38 | -- | -- | 0.00 | -- | 881.54 | 246.27 | 80.90 | -- | 7.61 | -- |
| Merus NV | 45.63m | -63.64m | 702.41m | 121.00 | -- | 2.35 | -- | 15.39 | -1.45 | -1.45 | 1.05 | 6.45 | 0.1184 | -- | 15.56 | 377,099.20 | -16.51 | -24.71 | -20.04 | -29.16 | -- | -- | -139.48 | -178.24 | -- | -- | 0.00 | -- | 64.00 | 77.64 | 21.86 | -- | 9.66 | -- |
| Allovir Inc | 0.00 | -188.52m | 706.18m | 107.00 | -- | 2.77 | -- | -- | -2.79 | -2.79 | 0.00 | 2.73 | 0.00 | -- | -- | 0.00 | -61.79 | -- | -66.69 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -146.42 | -- | -- | -- |
| Allakos Inc | 0.00 | -371.33m | 707.19m | 192.00 | -- | 2.05 | -- | -- | -6.76 | -6.76 | 0.00 | 4.04 | 0.00 | -- | -- | 0.00 | -71.43 | -32.18 | -76.45 | -33.39 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -75.83 | -- | 169.43 | -- |
| Exscientia PLC (ADR) | 43.98m | -84.95m | 709.01m | 287.00 | -- | 1.08 | -- | 16.12 | -0.7015 | -0.7015 | 0.365 | 5.35 | 0.0741 | -- | 81.49 | 153,251.50 | -14.32 | -- | -15.98 | -- | 32.57 | -- | -193.15 | -- | 9.08 | -- | 0.0123 | -- | 182.87 | -- | -120.94 | -- | -- | -- |
| POINT Biopharma Global Inc | 0.00 | -79.17m | 709.93m | 72.00 | -- | 2.26 | -- | -- | -0.8713 | -0.8713 | 0.00 | 2.97 | 0.00 | -- | -- | 0.00 | -26.26 | -- | -27.39 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -243.25 | -- | -- | -- |
| Aurinia Pharmaceuticals Inc | 129.00m | -115.46m | 720.50m | 300.00 | -- | 1.70 | -- | 5.59 | -0.8297 | -0.8297 | 0.9239 | 2.98 | 0.3041 | 0.2144 | 5.00 | 429,996.70 | -27.22 | -35.60 | -30.03 | -37.81 | 96.29 | -- | -89.50 | -523.03 | 10.40 | -- | 0.00 | -- | -9.00 | 204.93 | -76.24 | -- | 126.82 | -- |
| Invitae Corp | 519.97m | -3.21bn | 721.40m | 2.30k | -- | 4.54 | -- | 1.39 | -13.84 | -13.84 | 2.25 | 0.6542 | 0.1465 | 13.89 | 7.05 | 173,323.30 | -90.50 | -19.73 | -94.07 | -20.75 | 19.13 | 32.19 | -617.65 | -121.68 | 6.18 | -14.59 | 0.9096 | -- | 64.68 | 79.01 | 37.06 | -- | 36.32 | -- |
| Theravance Biopharma Inc | 51.64m | -82.19m | 727.55m | 158.00 | -- | 1.51 | -- | 14.09 | -1.10 | 11.25 | 0.6862 | 7.13 | 0.0885 | -- | 3.67 | 326,854.40 | -14.09 | -50.90 | -17.15 | -62.74 | -- | -- | -159.16 | -439.62 | -- | -- | 0.00 | -- | -23.03 | 2.60 | 28.27 | -- | 9.79 | -- |
Data as of Dec 02 2022. Currency figures normalised to Merus NV's reporting currency: US Dollar USD
42.38%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Federated Global Investment Management Corp.as of 30 Sep 2022 | 3.60m | 7.84% |
| BVF Partners LPas of 30 Sep 2022 | 3.44m | 7.51% |
| Commodore Capital LPas of 30 Sep 2022 | 2.62m | 5.70% |
| Deerfield Management Co. LPas of 30 Sep 2022 | 2.52m | 5.50% |
| Wellington Management Co. LLPas of 30 Sep 2022 | 1.94m | 4.22% |
| Aquilo Capital Management LLCas of 30 Sep 2022 | 1.51m | 3.29% |
| Driehaus Capital Management LLCas of 30 Sep 2022 | 1.10m | 2.40% |
| Woodline Partners LPas of 30 Sep 2022 | 1.05m | 2.29% |
| Franklin Advisers, Inc.as of 30 Sep 2022 | 1.05m | 2.28% |
| Samlyn Capital LLCas of 30 Sep 2022 | 617.65k | 1.35% |
More ▼
Data from 30 Sep 2022 - 30 Sep 2022Source: FactSet Research Systems Inc.
